Driscoll DA, Mennuti MT. Genetic defects and gene therapy. In: Spitzer AR, Ed. Intensive Care of the Fetus and Neonate. St. Louis: Mosby; 1996; 164-177.

Rios A, Furdon SA, Adams D, Clark DA. Recognizing the clinical features of trisomy 13 syndrome. Adv Neonatal Care 2004; 4(6): 332-343.

Simpson JL, Elias S. Chromosomal abnormalities. In: Simpson JL, Elias S, Eds. Genetics in Obstetrics and Gynecology, 3rd ed. Philadelphia: WB Saunders. 2003; 3-38.

Ishikiriyama S, Niikawa N. Origins of extra chromosomes in Patau syndrome. Hum Genet 1984; 68(3): 266-268.

Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13 year incidence study in Arhus, Denmark. Hum Genet 1991; 87(1): 81-83.

Biricik A, Guney I, Berkil H, Benkhalifa M, Kah raman S. A male (15;15) robertsonian translocation case with 11 previous consecutive recurrent spontaneous abortions. Marmara Med J 2004; 17(1): 35-38.

Jacobs PA. Mutation rates of structural chromosome rearrangements in man. Am J Hum Genet 1981; 33(1): 44-54.

Pellestor F. Analysis of meiotic segregation in a man heterozygous for a 13;15 Robertsonian translocation and a review of the literature. Hum Genet 1990; 85(1): 49-54.

Hook EB. Rates of 47,+13 and 46 translocation D/13 Patau Syndrome in live births and comparison with rates in fetal deaths and at amniocentesis. Am J Hum Genet 1980; 32(6): 849-858.

[www.who.int/entity/genomics/about/en/ trisomy13.pdf. (Accessed 06/18/08)].

Mandahl N. Methods in solid tumour cytogenetics. In: Rooney DE, Czepulkowski BH, Eds. Human Cyto genetics: A Practical Approach, 2nd ed. Oxford: IRL Press at Oxford University Press. 1992;155-187.

ISCN 2005: an international system for human cytogenetic nomenclature (2005): recommendations of the International Standing Committee of Human Cytogenetic Nomenclature. In: Shaffer LG, Tommerup N, Eds. Basel: S. Karger, 2005.

Bugge M, deLozier-Blanchet C, Bak M, Brandt CA, Hertz JM, Nielsen JB, Duprez L, Petersen MB. Tri somy 13 due to rea(13q; 13q) is caused by i(13) and not rob(13; 13)(q10; q10) in majority of cases. Am J Med Genet A. 2005; 132(3): 310-313.

Grasso M, Giovannucci Uzielli ML, Pierluigi M, Tavellini F, Perroni L, Dagna Bricarelli. Isochromosome not translocation in trisomy 21q21q. Hum Genet 1989; 84(1): 63-65.

Antonarakis SE, Adelsberger PA, Petersen MB, Binkert F, Schinzel AA. Analysis of DNA polymorphisms suggests that most de novo dup(21q) chromosomes in patients with Down syndrome are isochromosomes and not translocations. Am J Hum Genet 1990; 47(6): 968-972.

Shaffer LG, Jackson-Cook CK, Meyer JM, Brown JA, Spence JE. A molecular genetic approach to the identification of isochromosomes of chromosome 21. Hum Genet 1991; 86(4): 375-382.

Shaffer LG, McCaskill C, Haller V, Brown JA, Jackson-Cook CK. Further characterization of 19 cases of rea(21q;21q) and delineation as isochromosomes or Robertsonian translocations in Down syndrome. Am J Med Genet 1993; 47(8): 1218-1222.

Hassold T, Jacobs PA, Leppert M, Sheldon M. Cytogenetic and molecular studies of trisomy 13. Am J Med Genet 1987; 24(12): 725-732.

Shaffer LG, McCaskill C, Han J-Y, Choo KHA, Cutillo DM, Donnenfeld AE, Weiss L, Van Dyke DL. Molecular characterization of de novo secondary trisomy 13. Am J Hum Genet 1994; 55(5): 968-973.

Robinson WP, Bernasconi F, Dutly F, Lefort G, Romain DR, Binkert F, Schinzel AA. Molecular studies of translocations and trisomy involving chromosome 13. Am J Med Genet 1996; 61(2): 158-163.

Chen C-P, Chern S-R, Lee C-C, Chen L-F, Chuang C-Y, Chen M-H. Prenatal diagnosis of de novo isochro mosome 13q associated with microcephaly, alobar holo prosencephaly, and cebocephaly in a fetus. Prenat Diagn 1998; 18(4): 393-398.